Safety Netting Measures for Urinary Tract Infection (UTI)

Key Safety Netting Measures

Patients with UTI should be advised to seek immediate medical attention if symptoms do not resolve within 4 weeks after treatment completion, symptoms recur within 2 weeks, or if they develop signs of pyelonephritis such as fever, chills, flank pain, nausea, or vomiting, as recommended by the European Urology guidelines 1
Patients should return promptly if they develop signs of pyelonephritis including fever, chills, flank pain, nausea, vomiting, or tenderness at the costovertebral angle, according to the European Urology guidelines 1, 2
Routine post-treatment urinalysis or urine cultures are NOT indicated for asymptomatic patients, as stated by the European Urology guidelines 1
For patients whose symptoms do not resolve by the end of treatment or recur within 2 weeks, a urine culture with antimicrobial susceptibility testing should be performed, as recommended by the European Urology guidelines 1, 3

Patients with risk factors for complicated UTI require closer monitoring and potentially different management approaches, including those with urinary tract obstruction, foreign bodies, incomplete voiding, vesicoureteral reflux, recent instrumentation, diabetes mellitus, immunosuppression, and pregnancy, according to the European Urology guidelines 4, 5
For patients with pyelonephritis who remain febrile after 72 hours of treatment or experience clinical deterioration, additional investigations such as contrast-enhanced CT scan should be considered, as recommended by the European Urology guidelines 6

Diagnose recurrent UTI via urine culture, which is a strong recommendation by the European Urology guidelines 7, 8
Advise patients on preventive measures, including avoidance of risk factors, non-antimicrobial measures, and antimicrobial prophylaxis, as recommended by the European Urology guidelines 3, 6, 8
For patients with good compliance, self-administered short-term antimicrobial therapy should be considered, which is a strong recommendation by the European Urology guidelines 7, 8

For patients requiring hospitalization for pyelonephritis, monitor for clinical improvement within 72 hours of initiating parenteral antibiotics, as recommended by the European Urology guidelines 2, 9

Do not perform extensive routine workup in women younger than 40 years with recurrent UTI and no risk factors, as stated by the European Urology guidelines 7, 8
Avoid using fluoroquinolones for empirical treatment of complicated UTI in patients from urology departments or when patients have used fluoroquinolones in the last 6 months due to increasing resistance, as recommended by the European Urology guidelines 5
Be aware that UTI symptoms without resolution after appropriate treatment may indicate underlying structural or functional abnormalities requiring further investigation, according to the European Urology guidelines 4